| Name | MK-8666 |
|---|
| Description | MK-8666 is a selective partial GPR40 agonist developed for the treatment of type 2 diabetes mellitus. |
|---|---|
| References | 1. Lu J, et al. Nat Struct Mol Biol. 2017 Jul;24(7):570-577. 2. Krug AW, et al. Clin Transl Sci. 2017 Sep;10(5):404-411. |
| Molecular Formula | C29H31NO6S |
|---|---|
| Molecular Weight | 521.628 |